The global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market is witnessing steady expansion due to increasing awareness of prenatal health risks and improvements in diagnostic technologies. These tests play a crucial role in identifying complications during pregnancy that may lead to premature birth or rupture of the amniotic sac, enabling healthcare professionals to intervene early and improve maternal and neonatal outcomes.

According to industry estimates, the global preterm birth and PROM testing market was valued at US$ 227.8 Mn in 2023. The market is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2034, reaching US$ 562.1 Mn by the end of 2034. Growing prevalence of preterm births, rapid advancements in prenatal diagnostic technologies, and increased investments in maternal healthcare services are among the key factors driving market growth.

Market Overview

Preterm birth and PROM testing involves diagnostic procedures used to determine the risk of premature delivery. Premature rupture of membranes occurs when the amniotic sac surrounding the fetus breaks before labor begins, which may lead to infections, complications, or early childbirth.

These diagnostic tests help healthcare professionals detect risks early and implement appropriate management strategies such as medication, lifestyle adjustments, bed rest, or specialized neonatal care. Hospitals, prenatal care centers, and gynecology clinics widely use these testing methods to ensure timely intervention and minimize complications.

In recent years, technological advancements have enhanced the reliability and speed of these tests. Innovations in biomarker testing, molecular diagnostics, and imaging technologies are significantly improving the accuracy of early risk detection. Additionally, the integration of artificial intelligence and data analytics is enabling more precise prediction of preterm birth risks.

Rising Prevalence of Preterm Births Driving Market Demand

One of the primary drivers of the preterm birth and PROM testing market is the growing prevalence of premature births worldwide. Several factors such as lifestyle changes, increasing maternal age, rising stress levels, and the prevalence of chronic health conditions among pregnant women are contributing to this trend.

Socioeconomic factors also influence access to prenatal healthcare services, further affecting pregnancy outcomes. In many developing regions, limited access to proper prenatal care increases the risk of undetected pregnancy complications.

According to the World Health Organization, the global preterm birth rate ranges between 4% and 16% of babies born annually, with approximately 13.4 million babies born prematurely each year. A significant portion of these deaths and complications can be prevented through timely diagnosis and medical intervention.

Preterm birth and PROM testing play a critical role in identifying women at risk of premature delivery. Early detection allows healthcare providers to implement preventive measures such as administering medications, recommending lifestyle changes, or preparing specialized neonatal care facilities to improve survival rates and reduce infant morbidity.

Advancements in Diagnostic Technologies Boosting Market Growth

Technological advancements in prenatal diagnostics are significantly influencing the growth of the preterm birth and PROM testing industry. Modern diagnostic tools are increasingly focused on improving test accuracy, reducing invasiveness, and delivering faster results.

Molecular diagnostic technologies such as next-generation sequencing (NGS) are enabling researchers to analyze genetic markers associated with pregnancy complications. These technologies allow healthcare providers to identify potential risks earlier and with greater precision.

Advanced imaging technologies, including 3D ultrasound, are also improving prenatal monitoring by providing detailed visualization of fetal development and uterine conditions. Such innovations help clinicians detect abnormalities that may lead to premature birth.

Another significant trend is the development of point-of-care testing devices that allow rapid screening in clinical settings. These portable diagnostic tools enable healthcare professionals to perform tests quickly and efficiently, particularly in emergency or remote healthcare environments.

The integration of machine learning algorithms and artificial intelligence into diagnostic systems is further enhancing predictive capabilities. AI-driven data analysis can help identify patterns and risk factors associated with preterm births, enabling healthcare providers to develop personalized prenatal care plans.

Increasing investments in medical technology and diagnostic research are also contributing to market expansion. Growing healthcare expenditure on diagnostic tools is supporting the development and adoption of advanced prenatal testing solutions.

Regional Outlook

North America held the largest share of the global preterm birth and PROM testing market in 2023. The region benefits from well-developed healthcare infrastructure, strong adoption of advanced medical technologies, and increasing awareness about prenatal care.

In the United States, the prevalence of preterm births remains a major healthcare concern. According to the National Center for Health Statistics, approximately 380,548 preterm births occurred in the U.S. in 2022, accounting for 10.4% of total live births. This high prevalence has increased the demand for early diagnostic testing and specialized prenatal care services.

Additionally, strong investments in healthcare research and the presence of leading diagnostic companies in North America continue to support the region’s market growth.

Meanwhile, the Asia Pacific region is expected to witness steady growth during the forecast period from 2024 to 2034. Rapid population growth, improving healthcare infrastructure, and increasing awareness about maternal health in countries such as China and India are driving the demand for preterm birth and PROM testing solutions.

Government initiatives aimed at reducing infant mortality rates and expanding prenatal care programs are also contributing to the region’s growing market potential.

Competitive Landscape

The global preterm birth and PROM testing market features a competitive landscape with several prominent medical diagnostic companies focusing on research, innovation, and strategic collaborations.

Key market players are investing in the development of advanced biomarker-based tests, genetic screening technologies, and point-of-care diagnostic tools to improve early risk detection and clinical outcomes.

Strategic initiatives such as mergers and acquisitions, partnerships with research institutions, and expansion into emerging markets are common strategies adopted by companies to strengthen their global presence.

Major companies operating in the market include QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex SA, Abbott, Laborie, Sera Prognostics, The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products.

Key Industry Development

In May 2022, Sera Prognostics partnered with the Newborn Foundation to launch the “Every Mother, Every Baby Project.” The initiative aims to raise awareness among healthcare professionals and policymakers regarding the importance of biomarker-driven risk assessment tests for preterm birth.

The program highlights the use of Sera’s PreTRM test, which helps identify pregnant women at risk of preterm delivery. By enabling early intervention strategies, the test contributes to improved neonatal health outcomes and reduced mortality and morbidity rates.

Conclusion

The global preterm birth and PROM testing market is expected to experience significant growth over the next decade due to rising prevalence of premature births, technological advancements in prenatal diagnostics, and increasing investments in maternal healthcare.

Innovations in molecular diagnostics, biomarker testing, and artificial intelligence-driven risk prediction tools are transforming prenatal care by enabling earlier and more accurate detection of pregnancy complications. As healthcare providers and governments continue to prioritize maternal and neonatal health, the adoption of advanced diagnostic solutions is expected to expand rapidly.

With growing awareness and improved access to prenatal healthcare services across emerging economies, the preterm birth and PROM testing market is poised to play a crucial role in reducing infant mortality rates and improving pregnancy outcomes worldwide.